Novo Nordisk is conducting a clinical trial to study safety outcomes of infants born to pregnant people exposed to Wegovy and other weight loss medications during pregnancy
Research shows injectable GHK-Cu can increase collagen I production by up to 70% in dermal fibroblasts and boost elastin synthesis by 30% across all tested concentrations
These findingsoriginating from landmark trials such as EMPA-REG OUTCOME, LEADER, and SUSTAIN-6have led to substantial revisions in international guidelines from the European Society of Cardiology, American College of Cardiology, and American Heart Association, which now recommend the use of SGLT2i or GLP-1 RAs, often in conjunction with metformin
New formula, with GHK-Cu peptides ingredients
Does Hers' patient intake require an in-person appointment
Rheumatoid arthritis and other inflammatory conditions